Details for: LAGE3

Gene ID: 8270

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: LAGE3

Ensembl ID: ENSG00000196976

Description: L antigen family member 3

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 27.21
    rCSI 24.57%
    PRS 64.74
  • fallopian tube secretory epithelial cell CL4030006
    CSI 24.14
    rCSI 23.24%
    PRS 67.35
  • pancreatic A cell CL0000171
    CSI 23.38
    rCSI 24.49%
    PRS 71.11
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 18.6
    rCSI 12.53%
    PRS 81.11
  • common dendritic progenitor CL0001029
    CSI 14.59
    rCSI 18.31%
    PRS 77.91
  • early lymphoid progenitor CL0000936
    CSI 11.89
    rCSI 10.44%
    PRS 72.94
  • granulocyte monocyte progenitor cell CL0000557
    CSI 11.55
    rCSI 10%
    PRS 72.43
  • common myeloid progenitor CL0000049
    CSI 10.05
    rCSI 8.13%
    PRS 69.43
  • primitive red blood cell CL0002355
    CSI 9.79
    rCSI 52.84%
    PRS 77.95
  • promyelocyte CL0000836
    CSI 9.55
    rCSI 13.78%
    PRS 75.95
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 8.87
    rCSI 5.24%
    PRS 84.55
  • type B pancreatic cell CL0000169
    CSI 7.96
    rCSI 17.61%
    PRS 65.96
  • ciliated cell CL0000064
    CSI 7.38
    rCSI 11.96%
    PRS 63.6
  • group 3 innate lymphoid cell CL0001071
    CSI 7.07
    rCSI 5.31%
    PRS 73.42
  • lung secretory cell CL1000272
    CSI 6.92
    rCSI 17.12%
    PRS 66.35
  • mature B cell CL0000785
    CSI 6.65
    rCSI 5.78%
    PRS 78.26
  • duct epithelial cell CL0000068
    CSI 6.07
    rCSI 8.89%
    PRS 72.39
  • pancreatic D cell CL0000173
    CSI 5.84
    rCSI 5.75%
    PRS 70.28
  • pulmonary artery endothelial cell CL1001568
    CSI 5.66
    rCSI 7.71%
    PRS 78.66
  • plasmacytoid dendritic cell, human CL0001058
    CSI 5.54
    rCSI 3.87%
    PRS 70.54
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 5.36
    rCSI 15.38%
    PRS 86.58
  • retina horizontal cell CL0000745
    CSI 5.18
    rCSI 7.9%
    PRS 63.96
  • fibroblast of lung CL0002553
    CSI 5.17
    rCSI 4.81%
    PRS 68.35
  • alternatively activated macrophage CL0000890
    CSI 5.15
    rCSI 6.47%
    PRS 79.08
  • interneuron CL0000099
    CSI 5.06
    rCSI 10.17%
    PRS 56.85
  • immature B cell CL0000816
    CSI 4.76
    rCSI 3.54%
    PRS 80.6
  • respiratory suprabasal cell CL4033048
    CSI 4.55
    rCSI 5.83%
    PRS 72.15
  • dendritic cell, human CL0001056
    CSI 4.52
    rCSI 6.94%
    PRS 76.99
  • double negative thymocyte CL0002489
    CSI 4.48
    rCSI 3.11%
    PRS 79.07
  • interstitial cell of Cajal CL0002088
    CSI 4.39
    rCSI 5.58%
    PRS 73.77
  • mammary gland epithelial cell CL0002327
    CSI 4.32
    rCSI 15.16%
    PRS 78.83
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 4.16
    rCSI 3.33%
    PRS 85.93
  • lung macrophage CL1001603
    CSI 3.97
    rCSI 8.87%
    PRS 75.39
  • Langerhans cell CL0000453
    CSI 3.97
    rCSI 6.06%
    PRS 82.08
  • intermediate monocyte CL0002393
    CSI 3.83
    rCSI 5.78%
    PRS 72.59
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 3.75
    rCSI 2.85%
    PRS 80.65
  • cerebral cortex endothelial cell CL1001602
    CSI 3.74
    rCSI 6.47%
    PRS 58.06
  • memory T cell CL0000813
    CSI 3.63
    rCSI 6.99%
    PRS 90.33
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 3.57
    rCSI 18.45%
    PRS 87.17
  • epithelial cell of lower respiratory tract CL0002632
    CSI 3.55
    rCSI 2.75%
    PRS 70.63
  • T-helper 17 cell CL0000899
    CSI 3.48
    rCSI 2.77%
    PRS 87.5
  • erythrocyte CL0000232
    CSI 3.46
    rCSI 7.85%
    PRS 70.21
  • perivascular cell CL4033054
    CSI 3.43
    rCSI 4.69%
    PRS 73.39
  • neural crest cell CL0011012
    CSI 3.42
    rCSI 2.7%
    PRS 54.71
  • secretory cell CL0000151
    CSI 3.42
    rCSI 3.57%
    PRS 67.56
  • extravillous trophoblast CL0008036
    CSI 3.31
    rCSI 4.1%
    PRS 64.49
  • erythroid progenitor cell CL0000038
    CSI 3.11
    rCSI 17.84%
    PRS 75.65
  • epithelial cell of lung CL0000082
    CSI 3.07
    rCSI 2.55%
    PRS 67.3
  • hematopoietic precursor cell CL0008001
    CSI 2.87
    rCSI 2.96%
    PRS 82.54
  • ON-bipolar cell CL0000749
    CSI 2.85
    rCSI 4.23%
    PRS 68.56
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 2.71
    rCSI 2.66%
    PRS 82.84
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 2.67
    rCSI 3.64%
    PRS 89.56
  • rod bipolar cell CL0000751
    CSI 2.65
    rCSI 4.77%
    PRS 60.72
  • pro-B cell CL0000826
    CSI 2.65
    rCSI 2.19%
    PRS 70
  • naive T cell CL0000898
    CSI 2.63
    rCSI 1.83%
    PRS 82.62
  • placental villous trophoblast CL2000060
    CSI 2.63
    rCSI 4.06%
    PRS 66.12
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.62
    rCSI 2.67%
    PRS 79.24
  • stem cell CL0000034
    CSI 2.59
    rCSI 2.49%
    PRS 58.95
  • common lymphoid progenitor CL0000051
    CSI 2.58
    rCSI 3.45%
    PRS 86.27
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 2.58
    rCSI 7.61%
    PRS 70.06
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 2.55
    rCSI 2.35%
    PRS 85.62
  • nasal mucosa goblet cell CL0002480
    CSI 2.45
    rCSI 2.84%
    PRS 74.37
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 2.38
    rCSI 3.71%
    PRS 88.62
  • respiratory basal cell CL0002633
    CSI 2.37
    rCSI 2.45%
    PRS 73.44
  • CD4-positive helper T cell CL0000492
    CSI 2.36
    rCSI 1.79%
    PRS 81.04
  • transit amplifying cell of colon CL0009011
    CSI 2.24
    rCSI 2.63%
    PRS 69.59
  • hematopoietic stem cell CL0000037
    CSI 2.23
    rCSI 1.48%
    PRS 70.47
  • melanocyte CL0000148
    CSI 2.23
    rCSI 1.65%
    PRS 60.47
  • T follicular helper cell CL0002038
    CSI 2.21
    rCSI 1.65%
    PRS 82.09
  • OFF-bipolar cell CL0000750
    CSI 2.21
    rCSI 3.02%
    PRS 72.88
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 2.2
    rCSI 3.03%
    PRS 85.64
  • ionocyte CL0005006
    CSI 2.18
    rCSI 2.34%
    PRS 67.79
  • peripheral nervous system neuron CL2000032
    CSI 2.16
    rCSI 2.94%
    PRS 59.09
  • mucous neck cell CL0000651
    CSI 2.14
    rCSI 3.09%
    PRS 77.12
  • plasmablast CL0000980
    CSI 2.14
    rCSI 1.68%
    PRS 74.11
  • epithelial cell CL0000066
    CSI 2.13
    rCSI 3.28%
    PRS 61.01
  • activated type II NK T cell CL0000931
    CSI 2.07
    rCSI 2.33%
    PRS 83.54
  • ciliated epithelial cell CL0000067
    CSI 2.05
    rCSI 1.8%
    PRS 55.53
  • megakaryocyte CL0000556
    CSI 2.02
    rCSI 8.76%
    PRS 77.98
  • club cell CL0000158
    CSI 2
    rCSI 2.92%
    PRS 62.75
  • acinar cell CL0000622
    CSI 1.91
    rCSI 2.81%
    PRS 78.78
  • mesodermal cell CL0000222
    CSI 1.91
    rCSI 2.29%
    PRS 65.79
  • basal cell CL0000646
    CSI 1.9
    rCSI 2.55%
    PRS 67.63
  • pulmonary ionocyte CL0017000
    CSI 1.89
    rCSI 2.3%
    PRS 74.95
  • lung ciliated cell CL1000271
    CSI 1.86
    rCSI 2.15%
    PRS 58.33
  • pancreatic acinar cell CL0002064
    CSI 1.86
    rCSI 2.47%
    PRS 73.89
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 1.85
    rCSI 1.82%
    PRS 86.2
  • multi-ciliated epithelial cell CL0005012
    CSI 1.83
    rCSI 1.83%
    PRS 61.07
  • respiratory hillock cell CL4030023
    CSI 1.8
    rCSI 3.22%
    PRS 79.96
  • alveolar adventitial fibroblast CL4028006
    CSI 1.79
    rCSI 2.82%
    PRS 70.09
  • pancreatic ductal cell CL0002079
    CSI 1.79
    rCSI 3.47%
    PRS 70.71
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.78
    rCSI 1.37%
    PRS 69.02
  • transit amplifying cell CL0009010
    CSI 1.76
    rCSI 2.69%
    PRS 79.62
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 1.75
    rCSI 2.24%
    PRS 64.28
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 1.72
    rCSI 8.65%
    PRS 80.2
  • goblet cell CL0000160
    CSI 1.71
    rCSI 1.62%
    PRS 66.63
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.71
    rCSI 2.06%
    PRS 76.62
  • intestinal epithelial cell CL0002563
    CSI 1.68
    rCSI 1.76%
    PRS 65.42
  • hepatocyte CL0000182
    CSI 1.66
    rCSI 2.98%
    PRS 67.06
  • pre-conventional dendritic cell CL0002010
    CSI 1.66
    rCSI 21.99%
    PRS 90.41
  • peptic cell CL0000155
    CSI 0.3
    rCSI 2.5%
    PRS 83.3%
  • respiratory goblet cell CL0002370
    CSI 0.3
    rCSI 2.9%
    PRS 80.3%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.3
    rCSI 1.6%
    PRS 91.2%
  • basal cell of epithelium of trachea CL1000348
    CSI 0.4
    rCSI 2.7%
    PRS 79.2%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 0.5
    rCSI 1.9%
    PRS 49.5%
  • Cajal-Retzius cell CL0000695
    CSI 0.5
    rCSI 4.1%
    PRS 76.8%
  • pancreatic stellate cell CL0002410
    CSI 0.5
    rCSI 3.1%
    PRS 75.2%
  • forebrain radial glial cell CL0013000
    CSI 0.6
    rCSI 1.8%
    PRS 72.0%
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 0.6
    rCSI 1.3%
    PRS 63.3%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 0.6
    rCSI 2.7%
    PRS 90.7%
  • pancreatic epsilon cell CL0005019
    CSI 0.6
    rCSI 2.9%
    PRS 81.8%
  • retinal cone cell CL0000573
    CSI 0.7
    rCSI 1.1%
    PRS 57.1%
  • tracheobronchial serous cell CL0019001
    CSI 0.7
    rCSI 3.0%
    PRS 78.7%
  • vascular associated smooth muscle cell CL0000359
    CSI 0.7
    rCSI 2.3%
    PRS 67.1%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.7
    rCSI 2.3%
    PRS 50.7%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 0.7
    rCSI 1.8%
    PRS 47.3%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 0.7
    rCSI 1.8%
    PRS 83.9%
  • stromal cell of ovary CL0002132
    CSI 0.8
    rCSI 2.2%
    PRS 78.8%
  • thymocyte CL0000893
    CSI 0.9
    rCSI 3.0%
    PRS 92.6%
  • pancreatic PP cell CL0002275
    CSI 0.9
    rCSI 3.5%
    PRS 78.3%
  • intraepithelial lymphocyte CL0002496
    CSI 1.0
    rCSI 2.6%
    PRS 91.5%
  • ventricular cardiac muscle cell CL2000046
    CSI 1.0
    rCSI 3.3%
    PRS 85.0%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 1.0
    rCSI 1.9%
    PRS 83.5%
  • glutamatergic neuron CL0000679
    CSI 1.1
    rCSI 2.2%
    PRS 56.9%
  • promonocyte CL0000559
    CSI 1.1
    rCSI 1.9%
    PRS 75.7%
  • IgG plasma cell CL0000985
    CSI 1.1
    rCSI 1.3%
    PRS 82.6%
  • large pre-B-II cell CL0000957
    CSI 1.1
    rCSI 3.1%
    PRS 77.5%
  • foveolar cell of stomach CL0002179
    CSI 1.1
    rCSI 2.4%
    PRS 77.1%
  • sst GABAergic cortical interneuron CL4023017
    CSI 1.1
    rCSI 1.5%
    PRS 50.3%
  • tracheal goblet cell CL1000329
    CSI 1.1
    rCSI 2.5%
    PRS 79.0%
  • erythroblast CL0000765
    CSI 1.2
    rCSI 3.2%
    PRS 77.5%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 1.2
    rCSI 2.2%
    PRS 48.0%
  • mature alpha-beta T cell CL0000791
    CSI 1.3
    rCSI 4.6%
    PRS 85.9%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.3
    rCSI 2.2%
    PRS 84.1%
  • pluripotent stem cell CL0002248
    CSI 1.3
    rCSI 39.5%
    PRS 84.4%
  • fraction A pre-pro B cell CL0002045
    CSI 1.3
    rCSI 1.5%
    PRS 83.9%
  • muscle cell CL0000187
    CSI 1.4
    rCSI 2.8%
    PRS 83.6%
  • elicited macrophage CL0000861
    CSI 1.4
    rCSI 1.3%
    PRS 76.7%
  • granulocyte CL0000094
    CSI 1.4
    rCSI 2.1%
    PRS 76.8%
  • glioblast CL0000030
    CSI 1.4
    rCSI 2.2%
    PRS 59.7%
  • retinal ganglion cell CL0000740
    CSI 1.4
    rCSI 3.1%
    PRS 53.5%
  • bronchus fibroblast of lung CL2000093
    CSI 1.4
    rCSI 1.2%
    PRS 68.1%
  • alveolar macrophage CL0000583
    CSI 1.5
    rCSI 2.4%
    PRS 73.1%
  • erythroid lineage cell CL0000764
    CSI 1.5
    rCSI 9.7%
    PRS 82.6%
  • mononuclear phagocyte CL0000113
    CSI 1.6
    rCSI 3.4%
    PRS 71.8%
  • enteroendocrine cell CL0000164
    CSI 1.6
    rCSI 2.2%
    PRS 68.6%
  • mucus secreting cell CL0000319
    CSI 1.6
    rCSI 2.5%
    PRS 78.0%
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 1.6
    rCSI 1.8%
    PRS 60.3%
  • mesenchymal cell CL0008019
    CSI 1.6
    rCSI 4.0%
    PRS 61.4%
  • myeloid leukocyte CL0000766
    CSI 1.6
    rCSI 1.5%
    PRS 69.4%
  • radial glial cell CL0000681
    CSI 1.6
    rCSI 2.2%
    PRS 66.2%
  • colon epithelial cell CL0011108
    CSI 1.6
    rCSI 1.7%
    PRS 64.3%
  • intestine goblet cell CL0019031
    CSI 1.7
    rCSI 1.5%
    PRS 65.3%
  • enteric smooth muscle cell CL0002504
    CSI 1.7
    rCSI 2.4%
    PRS 69.5%
  • pre-conventional dendritic cell CL0002010
    CSI 1.7
    rCSI 22.0%
    PRS 90.4%
  • hepatocyte CL0000182
    CSI 1.7
    rCSI 3.0%
    PRS 67.1%
  • intestinal epithelial cell CL0002563
    CSI 1.7
    rCSI 1.8%
    PRS 65.4%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.7
    rCSI 2.1%
    PRS 76.6%
  • goblet cell CL0000160
    CSI 1.7
    rCSI 1.6%
    PRS 66.6%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 1.7
    rCSI 8.7%
    PRS 80.2%
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 1.8
    rCSI 2.2%
    PRS 64.3%
  • transit amplifying cell CL0009010
    CSI 1.8
    rCSI 2.7%
    PRS 79.6%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.8
    rCSI 1.4%
    PRS 69.0%
  • pancreatic ductal cell CL0002079
    CSI 1.8
    rCSI 3.5%
    PRS 70.7%
  • alveolar adventitial fibroblast CL4028006
    CSI 1.8
    rCSI 2.8%
    PRS 70.1%
  • respiratory hillock cell CL4030023
    CSI 1.8
    rCSI 3.2%
    PRS 80.0%
  • multi-ciliated epithelial cell CL0005012
    CSI 1.8
    rCSI 1.8%
    PRS 61.1%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 1.9
    rCSI 1.8%
    PRS 86.2%
  • pancreatic acinar cell CL0002064
    CSI 1.9
    rCSI 2.5%
    PRS 73.9%
  • lung ciliated cell CL1000271
    CSI 1.9
    rCSI 2.2%
    PRS 58.3%
  • pulmonary ionocyte CL0017000
    CSI 1.9
    rCSI 2.3%
    PRS 75.0%
  • basal cell CL0000646
    CSI 1.9
    rCSI 2.6%
    PRS 67.6%
  • mesodermal cell CL0000222
    CSI 1.9
    rCSI 2.3%
    PRS 65.8%
  • acinar cell CL0000622
    CSI 1.9
    rCSI 2.8%
    PRS 78.8%
  • club cell CL0000158
    CSI 2.0
    rCSI 2.9%
    PRS 62.8%
  • megakaryocyte CL0000556
    CSI 2.0
    rCSI 8.8%
    PRS 78.0%
  • ciliated epithelial cell CL0000067
    CSI 2.1
    rCSI 1.8%
    PRS 55.5%
  • activated type II NK T cell CL0000931
    CSI 2.1
    rCSI 2.3%
    PRS 83.5%
  • epithelial cell CL0000066
    CSI 2.1
    rCSI 3.3%
    PRS 61.0%
  • plasmablast CL0000980
    CSI 2.1
    rCSI 1.7%
    PRS 74.1%
  • mucous neck cell CL0000651
    CSI 2.1
    rCSI 3.1%
    PRS 77.1%
  • peripheral nervous system neuron CL2000032
    CSI 2.2
    rCSI 2.9%
    PRS 59.1%
  • ionocyte CL0005006
    CSI 2.2
    rCSI 2.3%
    PRS 67.8%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 2.2
    rCSI 3.0%
    PRS 85.6%
  • OFF-bipolar cell CL0000750
    CSI 2.2
    rCSI 3.0%
    PRS 72.9%
  • T follicular helper cell CL0002038
    CSI 2.2
    rCSI 1.7%
    PRS 82.1%
  • melanocyte CL0000148
    CSI 2.2
    rCSI 1.7%
    PRS 60.5%
  • hematopoietic stem cell CL0000037
    CSI 2.2
    rCSI 1.5%
    PRS 70.5%
  • transit amplifying cell of colon CL0009011
    CSI 2.2
    rCSI 2.6%
    PRS 69.6%
  • CD4-positive helper T cell CL0000492
    CSI 2.4
    rCSI 1.8%
    PRS 81.0%
  • respiratory basal cell CL0002633
    CSI 2.4
    rCSI 2.5%
    PRS 73.4%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 2.4
    rCSI 3.7%
    PRS 88.6%
  • nasal mucosa goblet cell CL0002480
    CSI 2.5
    rCSI 2.8%
    PRS 74.4%
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 2.6
    rCSI 2.4%
    PRS 85.6%
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 2.6
    rCSI 7.6%
    PRS 70.1%
  • common lymphoid progenitor CL0000051
    CSI 2.6
    rCSI 3.5%
    PRS 86.3%
  • stem cell CL0000034
    CSI 2.6
    rCSI 2.5%
    PRS 59.0%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.6
    rCSI 2.7%
    PRS 79.2%
  • placental villous trophoblast CL2000060
    CSI 2.6
    rCSI 4.1%
    PRS 66.1%
  • naive T cell CL0000898
    CSI 2.6
    rCSI 1.8%
    PRS 82.6%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [LAGE3](/details-gene/8270) (L antigen family member 3) is a ubiquitously expressed protein-coding gene located on the X chromosome at position Xq28. It is a member of the NY-ESO-1 gene family and is evolutionarily conserved ([Link](https://doi.org/10.1016/s0378-1119(02)00879-x)). Functionally, [LAGE3](/details-gene/8270) is a core subunit of the EKC/KEOPS (Endopeptidase-like complex/Kinase, Endopeptidase and Other Proteins of Small size) complex, which plays a critical role in the universal N6-threonylcarbamoylation (t6A) modification of transfer RNAs (tRNAs) ([Link](https://doi.org/10.1093/nar/gkw1181)). This modification is essential for translational fidelity and efficiency. Reflecting this fundamental role, the gene shows significant expression across a wide range of cell types, with particularly high significance in highly proliferative or metabolically active cells, such as hematopoietic progenitors and secretory epithelial cells. Clinically, mutations in genes of the KEOPS complex are associated with rare developmental disorders, including Galloway-Mowat syndrome ([301006](https://omim.org/entry/301006)) ([Link](https://doi.org/10.1038/s41467-019-11951-x)) and nephrotic syndrome with primary microcephaly ([300060](https://omim.org/entry/300060)) ([Link](https://doi.org/10.1038/ng.3933)). ## Cellular Roles and Expression Landscape The expression profile of [LAGE3](/details-gene/8270) underscores its fundamental role in cellular metabolism, particularly in protein synthesis. **Overall**, the gene is not restricted to a single lineage but exhibits high significance in diverse cell populations characterized by high rates of proliferation or protein production. The most significant expression is observed in hematopoietic progenitor cells, including [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 27.21), [common dendritic progenitor](/details-cell/CL0001029) (CSI: 14.59), [early lymphoid progenitor](/details-cell/CL0000936) (CSI: 11.89), and [granulocyte monocyte progenitor cell](/details-cell/CL0000557) (CSI: 11.55). This pattern suggests that robust tRNA modification machinery, involving [LAGE3](/details-gene/8270), is crucial for supporting the rapid cell division and differentiation programs that define hematopoiesis. A second major group of cells with high [LAGE3](/details-gene/8270) significance includes secretory and endocrine epithelial cells. This is highlighted by its high CSI in [fallopian tube secretory epithelial cell](/details-cell/CL4030006) (CSI: 24.14), [pancreatic A cell](/details-cell/CL0000171) (CSI: 23.38), and [type B pancreatic cell](/details-cell/CL0000169) (CSI: 7.96). These cells are tasked with synthesizing and secreting large quantities of proteins (e.g., hormones like glucagon and insulin), a process that places heavy demands on the translational machinery for both speed and accuracy, consistent with the gene's function in tRNA modification. Finally, significant expression is also noted in mature, active immune cells such as [central memory CD8-positive, alpha-beta T cell](/details-cell/CL0000907) (CSI: 18.60) and [central memory CD4-positive, alpha-beta T cell](/details-cell/CL0000904) (CSI: 8.87), which must be poised for rapid clonal expansion and effector function upon antigen recognition. The broad but elevated expression in these distinct, highly active cell types solidifies the role of [LAGE3](/details-gene/8270) as a key housekeeping gene essential for maintaining proteostasis under conditions of high metabolic demand. ## Pathways and Molecular Function [LAGE3](/details-gene/8270) is an integral component of fundamental RNA processing pathways. Its protein product functions as a core subunit of the EKC/KEOPS complex ([GO:0000408](https://www.ebi.ac.uk/QuickGO/term/GO:0000408)), which is localized to both the [cytoplasm](/details-go/GO:0005737) and the [nucleus](/details-go/GO:0005634) ([Link](https://doi.org/10.1371/journal.pone.0042822), [Link](https://doi.org/10.1093/nar/gkw1181)). The primary known function of this complex is the catalysis of t6A modification on ANN-decoding tRNAs. This is reflected in its annotation to specific biological processes: * **[Trna threonylcarbamoyladenosine metabolic process](/details-go/GO:0070525):** The direct metabolic pathway responsible for the t6A modification. * **[Trna processing](/details-go/GO:0008033):** A broader category encompassing modifications necessary for tRNA maturation and function. The Reactome database further situates these activities within the larger cellular context: * **[Trna modification in the nucleus and cytosol](/details-reactome/R-HSA-6782315):** This pathway highlights the spatial organization of tRNA maturation steps. * **[Trna processing](/details-reactome/R-HSA-72306):** Corroborates the GO annotation regarding its central role in preparing tRNA for translation. * **[Metabolism of rna](/details-reactome/R-HSA-8953854):** Places its function within the overarching framework of RNA lifecycle management. The necessity of the KEOPS complex and, by extension, [LAGE3](/details-gene/8270), is demonstrated by the severe phenotypes, including microcephaly and nephrotic syndrome, that arise from mutations in its components, which disrupt this essential tRNA modification ([Link](https://doi.org/10.1038/s41467-019-11951-x)). ## Research Directions The widespread and essential function of [LAGE3](/details-gene/8270) in tRNA modification provides a foundation for several specific, testable hypotheses regarding its role in cell-type-specific physiology and pathology. **Proposed Hypotheses:** 1. Given the exceptionally high CSI of [LAGE3](/details-gene/8270) in hematopoietic progenitors like the [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050), it is hypothesized that [LAGE3](/details-gene/8270)-mediated tRNA modification is a rate-limiting step for the translation of key lineage-specifying transcription factors (e.g., GATA1, KLF1). Partial loss-of-function in [LAGE3](/details-gene/8270) may therefore lead to specific cytopenias by creating bottlenecks in the differentiation of specific hematopoietic lineages. 2. The high significance of [LAGE3](/details-gene/8270) in professional secretory cells, such as [pancreatic A cell](/details-cell/CL0000171) and [type B pancreatic cell](/details-cell/CL0000169), suggests that its function is critical for maintaining proteostasis under high secretory load. It is hypothesized that reduced [LAGE3](/details-gene/8270) activity in these cells would increase mistranslation of pro-hormones (e.g., proglucagon, proinsulin), leading to activation of the unfolded protein response (UPR) and contributing to cellular dysfunction seen in metabolic diseases like diabetes. **Experimental Approach:** To test the hypothesis regarding hematopoietic differentiation (Hypothesis 1), a compelling experiment would involve the conditional knockout or shRNA-mediated knockdown of [LAGE3](/details-gene/8270) in primary human CD34+ hematopoietic stem and progenitor cells (HSPCs). These modified cells would then be cultured *in vitro* under conditions promoting erythroid and megakaryocytic differentiation. The primary readout would be flow cytometric quantification of lineage-specific markers (e.g., CD235a/CD41) to assess differentiation efficiency. To probe the mechanism, ribosome profiling (Ribo-Seq) could be performed on progenitor cells with and without [LAGE3](/details-gene/8270) knockdown to identify specific codons and transcripts that exhibit translational pausing, directly linking the loss of t6A modification to impaired synthesis of critical differentiation factors. **Therapeutic Potential:** As a ubiquitously expressed and essential housekeeping gene, [LAGE3](/details-gene/8270) is not a suitable target for systemic inhibition, which would likely result in severe, on-target toxicity in all proliferating tissues. Its therapeutic relevance lies primarily in the context of rare genetic diseases caused by mutations in the KEOPS complex. For these monogenic disorders, such as Galloway-Mowat syndrome, a deeper understanding of [LAGE3](/details-gene/8270) and its partners could inform the development of gene replacement therapies or small molecules designed to stabilize the mutant complex or enhance the activity of a partially functional enzyme. Therefore, strategies would focus on restoration or activation of function rather than inhibition.

Genular Protein ID: 2465907994

Symbol: LAGE3_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 15772651

Title: The DNA sequence of the human X chromosome.

PubMed ID: 15772651

DOI: 10.1038/nature03440

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 8786131

Title: Characterization and fine localization of two new genes in Xq28 using the genomic sequence/EST database screening approach.

PubMed ID: 8786131

DOI: 10.1006/geno.1996.0293

PubMed ID: 12384295

Title: A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved.

PubMed ID: 12384295

DOI: 10.1016/s0378-1119(02)00879-x

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 22912744

Title: The human EKC/KEOPS complex is recruited to Cullin2 ubiquitin ligases by the human tumour antigen PRAME.

PubMed ID: 22912744

DOI: 10.1371/journal.pone.0042822

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 27903914

Title: Proteomic analysis of the human KEOPS complex identifies C14ORF142 as a core subunit homologous to yeast Gon7.

PubMed ID: 27903914

DOI: 10.1093/nar/gkw1181

PubMed ID: 31481669

Title: Defects in t6A tRNA modification due to GON7 and YRDC mutations lead to Galloway-Mowat syndrome.

PubMed ID: 31481669

DOI: 10.1038/s41467-019-11951-x

PubMed ID: 28805828

Title: Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly.

PubMed ID: 28805828

DOI: 10.1038/ng.3933

Sequence Information:

  • Length: 143
  • Mass: 14804
  • Checksum: AD164559371449F8
  • Sequence:
  • MRDADADAGG GADGGDGRGG HSCRGGVDTA AAPAGGAPPA HAPGPGRDAA SAARGSRMRP 
    HIFTLSVPFP TPLEAEIAHG SLAPDAEPHQ RVVGKDLTVS GRILVVRWKA EDCRLLRISV 
    INFLDQLSLV VRTMQRFGPP VSR